Brenntag (FRA:BNR) received a €57.00 ($66.28) price objective from stock analysts at Warburg Research in a report issued on Monday, November 12th. The brokerage presently has a “buy” rating on the stock. Warburg Research’s price objective suggests a potential upside of 47.78% from the company’s previous close.
Several other analysts also recently weighed in on BNR. Berenberg Bank set a €57.00 ($66.28) price target on shares of Brenntag and gave the company a “neutral” rating in a research note on Monday, September 3rd. BNP Paribas set a €64.00 ($74.42) price target on shares of Brenntag and gave the company a “buy” rating in a research note on Tuesday, October 2nd. UBS Group set a €60.00 ($69.77) price target on shares of Brenntag and gave the company a “buy” rating in a research note on Monday, September 3rd. Nord/LB set a €53.00 ($61.63) price objective on shares of Brenntag and gave the company a “neutral” rating in a report on Tuesday, August 28th. Finally, equinet set a €59.80 ($69.53) price objective on shares of Brenntag and gave the company a “buy” rating in a report on Wednesday, August 8th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the company. The stock has an average rating of “Buy” and an average target price of €53.58 ($62.30).
FRA BNR traded up €0.14 ($0.16) during trading on Monday, hitting €38.57 ($44.85). The stock had a trading volume of 511,229 shares. Brenntag has a one year low of €43.06 ($50.07) and a one year high of €56.25 ($65.41).
Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.
Read More: 52-Week High/Low
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.